Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...
High quality growth: €104 million revenue at guidance midpoint (€102 to €107 million) with recurring revenues representing the majority of sales and accelerating year over year Strategic firepower: ...
Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued ...
The Uttar Pradesh Public Service Commission (UPPSC) has revised the main examination calendar for Review Officer (RO) and ...
Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
With higher education coming under a more permanent and scrutinizing legislative gaze last session with the establishment of ...
While some women sail through menopause with few bothersome symptoms, many spend years suffering or maybe just not feeling ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of ...
This study quantitatively investigates the relationship between the implementation of waste-to-resource systems and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback